The Philippine Competition Commission (PCC) has power to prohibit mergers and acquisition agreements that will likely result in substantial prevention, restriction, or lessening of competition (SLC) in the relevant market/s. However, remedies may be considered and accepted by the PCC in mergers and acquisitions that would otherwise be prohibited.

The PCC published the Guidelines on Merger Remedies (the Guidelines) to explain the PCC’s approach in assessing remedies for mergers and acquisitions that were found during review to likely result in SLC in identified relevant markets. More particularly, the Guidelines contain a discussion of the design, selection, and implementation of merger remedies.

For details, you may contact the Mergers and Acquisitions Office through landline +632 635 6214 or through e-mail at

Download (PCC-Guidelines-on-Merger-Remedies-01July2024.pdf)